The full agreement between Henry Schein and KKR will be filed on a Form 8-K with the Securities ... and preliminary earnings per share. Exhibit B includes a reconciliation of preliminary GAAP ...

BofA analyst Allen Lutz double upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69. The firm believes ...

BofA upgraded Henry Schein (HSIC) to Buy from Underperform on January 6, not tonight as previously reported in error.Maximize Your Portfolio ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...

Exhibit B includes a reconciliation of preliminary GAAP net income to preliminary Adjusted EBITDA. Henry Schein also today announced preliminary financial guidance for 2025. Revenues and non-GAAP ...

Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor disclosed a strategic investment of an additional $250 million from funds ...

This belief drove our collaboration with Henry Schein One, a division of Henry Schein, a leader in dental software solutions, to launch a dynamic new website designed to set the standard for ...

(Reuters) -Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the distributor of medical products said on Wednesday. Shares of ...

Nordea Investment Management AB boosted its stake in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 8.6% during the 4th quarter, according to its most recent Form 13F filing with the ...